Introduction {#Sec1}
============

The role of the immune system is to protect a body against bacterial, viral, or any foreign antigen invasions. In order to improve protection, vaccination is used to boost immunity against diseases caused by microorganisms. It typically contains a less virulent agent that triggers a reaction, thus, stimulating a body's immune system to recognize it as foreign. In the process, a body's defense mechanism learns to recognize and destroy a microorganism, its toxins or surface proteins \[[@CR94]\] every time an invasion is identified. The use of vaccination is important because it promotes the stimulation of the body's defense mechanisms and the development of both individual and collective immunity. Vaccination can act on specific (adaptive) and nonspecific (innate) immune responses unlike immunostimulants which only act on innate response. In addition, it should be noted the role vaccines play in controlling diseases as preventative as well as non-therapeutic measures. Therefore, the body is able to produce antibodies that recognize, signal and neutralize pathogens or particular cellular responses which detect the specific antigens with high efficiency and affinity. As a result, vaccines protect the body against future infections \[[@CR27]\] thus reducing the need for the use of antibiotics and other types of drugs.

Despite the study of immunology in fish being more recent compared to those of humans and in animals, the concepts and techniques used are similar \[[@CR60]\]. The study of the use of vaccines in fish is an area of fast-growing. As aquaculture expands and the need to control pathogens becomes more pressing, the commercial vaccination of different varieties of fish is already a reality in many countries. It aids in the prevention of diseases that could pose health risks to the shoal as well as in avoiding the economic losses due to mortality caused by infection. It reduces the contamination of water bodies by the excessive use of antibiotics, and the reduction of final fish product quality \[[@CR5], [@CR24], [@CR42], [@CR79], [@CR100]\].

The Zebrafish model has been widely used in both animal and human health research and, more recently, in aquaculture too. In spite of rodents being the most widely used research model in the world, in recent decades the use of the zebrafish (*Danio rerio*) model has exponentially increased among the scientific community. It follows the principle of 3Rs (replacement, reduction, and refinement) as required by a multiplicity of national and international regulatory bodies. Furthermore, the use of zebrafish model results in a reduction of time and use of resources when compared to those more established animals' models. It also provides a greater informational and predictive capacity when compared to in vitro results \[[@CR53]\]. Thus, using the zebrafish model, it is possible to replace and reduce the use of mammals in research as well as mitigate problems related to the welfare of those animals. Furthermore, zebrafish is used as confirmatory models of the positive previously obtained results, thus, having the ability to refine the findings \[[@CR2]\]. A review of the literature was carried out aiming at presenting the most recent information on vaccination of fish, which brings to light the advantages of this animal model in tests of efficacy and safety of both animal and human vaccines.

Material and methods {#Sec2}
====================

The present study was based on a systematic literature review carried out using databases such as Science Direct, Google Scholar and SciELO (Scientific Electronic Library Online). Emphasis was given on identifying publications using search words and terms containing 'human vaccination' and 'animal vaccination'. Particularly, the main key-words searched included 'Zebrafish model', 'vaccine safety', 'diseases', 'infection' and 'toxicology'. Initially, 99 publications were identified which included books, rulings and articles published by international scientific journals of high impact factor. The publications were selected according to relevance and timeliness. 19% of the articles used were published in the last year, 65% in the last 5 years, and 89% published in the last 10 years.

Discussion {#Sec3}
==========

Zebrafish model and vaccines testing {#Sec4}
------------------------------------

### Vaccination safety {#Sec5}

When devising immunization experiments, challenge trials for vaccine development evaluate the efficacy and safety of the vaccine against different pathogens. These are normally assessed using animal models, mainly mammals, which are often imprecise in reflecting human diseases \[[@CR93]\], not to mention time consuming, and require a large number of animals. Moreover, the mortality and clinical signs as well as laboratory tests are usually analyzed to evaluate the innate (non-specific) or adaptive (specific) immune system response. As in mammals, Zebrafish has a well-maintained adaptive immune system composed of T and B lymphocytes that develop from the thymus and kidneys respectively. However, in relation to the development of memory lymphocytes, fish seem to have memory cells of the type B and T \[[@CR78]\]. Yet, there has not been enough data to confirm that in Zebrafish. Zebrafish also presents the enzyme system involved in the process of genetic rearrangement that originates the B (BCR) and T (TCR) lymphocyte receptors. As in humans, Zebrafish has recombination activator genes that control the rearrangement of gene segments V, D and J to produce the diversity of antibodies and lymphocyte receptors. In addition, the zebrafish's immune system has only approximately 300,000 antibody-producing B cells, making it three orders of magnitude smaller than mice and five orders simpler than humans \[[@CR48]\].

The efficiency of the humoral response increases due to the increased affinity of the antibodies. Affinity maturation of antibody responses is less efficient in cold-blooded vertebrates compared to mammals. Despite this, in zebrafish, data revealed that specific nucleotides in regions of the BCR receptor were target of directed mutations. Therefore it was suggested that activation-induced deaminase and affinity maturation contributed to the diversification of antibodies also in fish \[[@CR56]\]. Immunization of teleost fish with the TNP-KLH antigen (linked to trinitrophenyl to keyhole limpet hemocyanin), for example, induced the production of specific low affinity antibodies, which were replaced in 5 weeks by antibodies of intermediate affinity, and after 15 weeks, by antibodies with greater affinity for the antigen \[[@CR28], [@CR97]\].

Among the immunological tests, the most frequent ones are: complete hematological analysis by counting erythrocytes; thrombocytes and leukocytes; differential white cell count; hematocrit; glucose; organ histology, and immunological essays such as serology, specific antibody titration, and agglutination \[[@CR4], [@CR29], [@CR57]\]. Furthermore, toxicity tests can be also conducted using zebrafish such as embryotoxicity, hepatotoxicity, neurotoxicity, endocrine toxicity, genotoxicity, among others as proposed by Bailone et al. \[[@CR3]\].

Up to now, these tests have been conducted using rodents, but in recent decades, the Zebrafish model has proved to be an important tool in the studies of infections and immunological responses. This model has the advantage of having OECD-specific guidelines for safety evaluation of chemical compounds (acute toxicity), which is performed within 96 h \[[@CR65]\]. In addition, observations can be made in real-time allowing for the monitoring of embryogenesis (Fig. [1](#Fig1){ref-type="fig"}) as well as regarding the effects of vaccines in relation to cardiovascular, hepatic, nervous, and endocrine, not to mention, behavioral aspects too \[[@CR18], [@CR40]\]. Fig. 1Embryos of zebrafish 0, 6, 24 and 48 h' post-fertilization. Larvae of zebrafish 72 and 96 h post-fertilization

Prior to vaccines being tested on humans, livestock or pets, these should be assessed using animal models to avoid causing them harm, including death, especially in the case of immunosuppressed organisms, children and the elderly \[[@CR26]\]. As for vaccination in humans, for example, about 0.4 to 1.9 people per million who had been vaccinated with BCG against tuberculosis may have developed the disease through vaccine contagion. For hepatitis B, 1 in 600,000 people vaccinated may have presented a severe allergic reaction (anaphylaxis). In the case of vaccine against poliomyelitis, vaccine contagion happened to 1 in every 3.6 million vaccinated. Moreover, to combat yellow fever, the vaccine contagion and seizures happened to 1 in 22 million and internal hemorrhages happened to 1 in 450,000. Thence, the occurrence of side effects is very rare. Side effect reactions in humans may also be observed to be caused by other vaccines such as yellow fever, measles, mumps, rubella, chicken pox, diphtheria and tetanus. The most common symptoms are seizures, severe allergic reactions, meningitis, encephalitis \[[@CR26]\]. Although these risks are irrelevant when compared to damages that could be caused by the non-use of a vaccine, the toxicology, the side effects and immunization at different concentrations ought to be adequately tested.

Thus, the Zebrafish model has the advantage of a researcher to follow in real-time the fish's development from its embryogenesis to full organ development which is reached about 36 h after fertilization. This allows for a vaccine's effect on all the major organs precursors to be closely studied \[[@CR53]\] such as using immunohistology (Fig. [2](#Fig2){ref-type="fig"}). Fig. 2Histology of adult zebrafish (hematoxylin eosin). **a** Male. **b** Female

Zebrafish and mammalian toxicity (Lethal concentration -- LC~50~) profiles are surprisingly similar for a range of substances specified in Table [1](#Tab1){ref-type="table"} below. Therefore, toxicity studies support the effectiveness of using the zebrafish model for the purpose of testing these substances. Furthermore, they can be extrapolated to the active ingredients present in the vaccine, and enabling quick parallel studies of vaccine reactions in humans and zebrafish. Table 1Range of drugs used in human medicine with similar results of toxicity (LC~50~) in zebrafishDrugUsed asGeladanamycinAntibioticEthanol (Ethyl alcohol)AntisepticDexamethasone (Corticosteroid)Anti-inflammatoryAcetaminophenAnalgesic/ antipyreticDoxorubicinUsed in cancer chemotherapyAspirin (Acetylsalicylic acid)Analgesic / antipyretic / anti-inflammatoryAmiodaroneAntiarrhythmic / potent vasodilatorTacrineReversible acetylcholinesterase inhibitorCyclosporine AImmunosupressor drugDidemnin BAntiviral / immunosuppressorSource: Adapted from Kari et al. \[[@CR43]\] *apud* Zhang et al. \[[@CR99]\]

### Advantages of zebrafish model in vaccination tests {#Sec6}

Compared to other vertebrates, zebrafish have extra biological advantages including high fecundity, external fertilization, optical transparency and rapid development. Moreover, Zebrafish possess a highly developed immune system that is remarkably similar to the human one. Therefore, it is expected that the majority of the signaling pathways and molecules involved in the immune response of mammals would also exist and behave similarly in fish \[[@CR89]\]. Consequently, the presence in fish of elements of innate and adaptive immunity enables research in infectious processes, being susceptible to infections by gram-negative and gram-positive bacteria, protozoa, viruses, fungi and mycobacteria.

The development of special cloning, mutagenesis and transgenesis techniques allowed the identification of a significant number of mutants. Commercial mutant zebrafish lines and the recently developed CRISPR/Cas9 genome modification system provide the means to create knockout zebrafish for studying individual genes at a whole organism level \[[@CR66]\]. Non-pigmenting mutants such as Casper zebrafish have also helped improve visibility of internal organs \[[@CR92]\]. In addition it is easy to generate transgenic zebrafish with 'reporter genes' to facilitate analysis in live fish \[[@CR87]\]. Because the zebrafish genome is conserved in humans, information obtained from zebrafish studies may lead to translational results in humans \[[@CR38]\].

Examples of mutant animals displaying human-like diseases are numerous such as: *sapje,* which has the gene homologous to that of Duchenne muscular dystrophy; *dracula*, related to erythropoietic protoporphyria; *van Gogh,* model of the DiGeorge syndrome; and *gridlock*, which induces coarctation of the aorta \[[@CR47]\]. Research in tumor suppressor genes *p53* and *apc* (*adenomatous polyposis coli)* is another area of great interest*.* The importance of the *p53* gene in human carcinogenesis is well recognized and recent studies have shown zebrafish as an excellent model for assessing the presence (or not) of gene stability. Lymphoid leukemia, melanoma and hepato-carcinoma have already been described in zebrafish thus confirming that the molecular mechanisms involved are similar to those of humans \[[@CR49]\].

Regarding the administration of vaccines, in view of the different routes of applications presented in animals and humans, the zebrafish model still allows the immunization of embryos, facilitated by its transparency, using glass needles (Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}). Interestingly, the fact that the fish's adaptive immune system does not reach maturity up to 4 weeks after fertilization allows them to be used without the need for immunosuppression in the embryonic stages \[[@CR32]\] in the case, for example, of tumor xenograft experiments. Fig. 3**a** Vitelline Yolk Injection (24 HPF), Magnifying Glass Nikon SMZ745, 50X; B) Vitelline Yolk Injection (24 h.p.f.), Magnifying Glass Nikon SMZ745, 50XFig. 4**a** 24 HPF Zebrafish Embryo Brain Injection, Nikon Microscope; **b** Brain injection of turbo-red substance into a 24 HPF zebrafish embryo; **c** Luciferin-labeled 4 T1 tumor cell bioluminescence in 3-month-old animals

In zebrafish larvae, a rapid systemic infection can be initiated by direct microinjection of a bacterial suspension into the bloodstream. Alternatively, a more localized infection may be induced by the injection of microbes into the muscle tail or the hindbrain ventricle \[[@CR6]\]. For high transfer rate, the microbes can be readily injected into the yolk for the first few hours after fertilization. However, it is important to keep in mind that the yolk lacks immune cells, and therefore the bacteria are able to grow freely before invading the larval tissues \[[@CR51]\].

Several transgenic zebrafish lines containing fluorescent markers in different cells of the immune system have been developed to visualize host-microbe interactions in the transparent larvae. For example, recruitment of fluorescent neutrophils to the site of bacterial infection (which can also be labeled with fluorescence) could be easily followed and quantified in real time. Yet, so far, researchers have focused primarily on larval infection patterns \[[@CR51]\].

### Fish vaccines {#Sec7}

In the prevention of disease outbreaks causing mortalities in aquaculture, similarly to any other animal production system, vaccination is essential. Thus, the use of vaccines for that purpose could be improved based on the results from the studies performed in zebrafish \[[@CR89]\]. The development of vaccines for aquaculture has been an important milestone for guaranteeing a continuous safe and high standard animal health production system. In recent years, zebrafish models have been chosen as the preferred model in the production of fish vaccination experiments against several pathogens that cause losses in aquaculture around the world such as bacteriosis and viruses. One of the most important pathogen studies applied to fishing production is attributed to Guo et al. \[[@CR35]\]. They analyzed the protective efficacy of four iron-related recombinant proteins and their single-walled carbon nanotube encapsulated counterparts against the *Aeromonas hydrophila* infection in zebrafish. They observed that the immune response was increased after vaccination. Guo et al. \[[@CR34]\] also studied *Edwardsiella tarda* which is an important intracellular pathogenic bacterium that causes the infectious disease Edwardsiellosis in fish. They proved that live *E. tarda* vaccine enhanced innate immunity by metabolic modulation in zebrafish.

*Vibrio anguillarum*, a bacterium that causes vibriosis, was also studied by Ye et al. \[[@CR98]\] who observed the maternal transfer and protection role in zebrafish offspring following vaccination of the brood stock with a live attenuated *V. anguillarum* vaccine. They proved that the development of immune cells was enhanced and the maternally-derived antibody could protect early embryos and larvae from the attack of specific pathogens via vaccination with a live attenuated vaccine. Furthermore, Liu et al. \[[@CR50]\] analyzed the profiling immune response in zebrafish intestine, skin, spleen and kidney when immersion vaccinated was used with a live attenuated V. anguillarum vaccine. Immersion, or bath vaccination, is a common practice in aquaculture, because of it being convenient as mass vaccination giving sufficient protection. The fish is submerged in water with a sub lethal concentration of the bacteria for a specific time. Liu et al. \[[@CR50]\] observed that antibodies were either produced at antigen-contact tissues or in immune organs. Zhang et al. \[[@CR101]\] studied Th17-like immune response in fish mucosal tissues after administration of live attenuated *V. anguillarum* via different vaccination routes. When compared to injection vaccination, immersion vaccination elicited intense Th17-like immune responses in the gut tissue of zebrafish. *Vibrio vulnificus*, that is an aquatic pathogen that can cause primary sepsis and soft tissue infection, was also tested during an experimentation of zebrafish's reaction to vaccine. It was concluded that CpG oligodeoxynucleotides, a type of essential immunomodulators, protected zebrafish against *Vibrio vulnificus* induced infection \[[@CR15]\].

*Francisella noatunensis* is a bacterium that causes granulomatous disease in freshwater and marine fish, and remains an unsolved problem for the aquaculture sector as no efficient vaccines are yet available. Lagos et al. \[[@CR46]\] studied the immunomodulatory properties of *Concholepas concholepas* hemocyanin against francisellosis in a zebrafish model, proving that his adjuvant was a potential one for aquaculture vaccines. Moreover, Brudal et al. \[[@CR11]\] observed that vaccination with outer membrane vesicles from *F. noatunensis* reduced the development of francisellosis in a zebrafish model.

Streptococcus sp. has also been studied with the Zebrafish model. *Streptococcus parauberis* is the major infectious agent of streptococcosis in olive flounder (*Paralichthys olivaceus*). Kim et al. \[[@CR45]\], studying the identification of novel immunogenic proteins against *S. parauberis* by reverse vaccinology using zebrafish model, identified 41 vaccine candidates against *S. parauberis.* Furthermore, *Streptococcus iniae* was studied by Membrebe et al. \[[@CR58]\] testing the protective efficacy of *Streptococcus iniae* derived enolase against Streptococcal infection in zebrafish model. In that study, enolase protein was evaluated to induce cross-protective immunity against *S. iniae* and *S. parauberis* which are major pathogens causing streptococcosis in fish.

Further to the aforementioned examples, many other diseases have been investigated with the Zebrafish model. For example, Rhabdovirus, which is one of the most important diseases in salmonids, is a virus that causes hemorrhagic viral septicemia \[[@CR44], [@CR64]\]. *Listeria monocytogenes* \[[@CR19], [@CR20]\]; *Piscirickettsia salmonis* which causes salmonid rickettsia sepsis (Tandberg et al. \[[@CR83]\]); and in adjuvant test to improve the efficacy of vaccines \[[@CR44]\], among others \[[@CR82]\].

### Animals and human vaccines {#Sec8}

The zebrafish model has been used not only in aquaculture, but also in veterinary and human medicine. So far, it has become one of the major model systems used in modern biomedical research \[[@CR51]\]. According to Torraca et al. \[[@CR86]\], zebrafish can be also used as a model for pathogenesis and host defense, modeling many human diseases, such as tuberculosis, *Staphylococcus aureus* and Shigella infection, among others, as well as model to investigate immune cells, infection and inflammation of different kind of human diseases.

Torraca et al. \[[@CR86]\] posited that zebrafish could also be used as a model for *Tuberculosis* which is a devastating infectious disease worldwide and with no current prospect of efficient prevention. Tuberculosis is an infectious disease caused by bacilli from the *Mycobacterium tuberculosis* complex. It is estimated that up to one third of the world's population is infected with *M. tuberculosis* and have active tuberculosis, which often develops decades after the primary infection. Annually about two million people perish of tuberculosis and, so far, due to the lack of well-established animal models, such a disease has been difficult to study \[[@CR51]\].

An infection by *Mycobacterium marinum* in adult zebrafish resembles that of human tuberculosis, as demonstrated by Myllymäki et al. \[[@CR62]\]. Those authors proved that the *M. marinum* infection model in adult zebrafish was suitable for preclinical screening of tuberculosis immune's responses and vaccines. It was also a promising new model for tuberculosis vaccine research, including the pre-clinical identification of vaccine antigens \[[@CR16], [@CR17], [@CR36], [@CR41], [@CR61], [@CR67]\];). Other species of *Mycobacterium* have also been studied, such as *M. bovis* \[[@CR52], [@CR73]\] and *M. abscessos* \[[@CR7]\]. *M. bovis* is most common in cattle, but also affects humans. *M. bovis* Bacillus Calmette-Guérin vaccine is currently available as a prophylactic tool for preventing the disease. It has been shown to be efficient in preventing disseminated forms of tuberculosis in children; however, its efficiency is limited in areas where individuals have had prior exposure to environmental mycobacteria, and its efficacy decreased with a host's age \[[@CR55]\].

Moreover, teleost models offer an expanding platform for the understanding of mycobacterial infections and those mechanisms that offer the greatest potential to enhance host protection \[[@CR37]\]. The models make it possible to screen the host and bacterial factors that modify the disease and facilitate the search for new therapeutic agents. It has recently been shown that zebrafish can also be used for the potential screening of DNA-based vaccines and, in particular, for identifying novel antigens protecting against mycobacteria \[[@CR67]\]. Therefore, using the Zebrafish model is expected to accelerate the understanding of the pathogenesis of tuberculosis which would lead to the development of better vaccines. Yet, the usefulness of this model is not limited to tuberculosis, which as seen before it could benefit research for many other important infectious diseases \[[@CR51]\].

Similarly, this model also helps to elucidate bacterial infections in animals and humans by *Aeromonas hydrophila* \[[@CR91]\], *Pseudomonas aeruginosa* \[[@CR74]\], *Escherichia coli* nonpathogenic \[[@CR63]\], *E. coli* CFT073 \[[@CR95]\], *Listeria monocytogenes* \[[@CR80], [@CR81]\], *Myroides odoratimimus* \[[@CR72]\], *Cronobacter turicensis* \[[@CR25]\], *Streptococcus agalactiae* \[[@CR70], [@CR96]\],  *Streptococcus iniae* and *Streptococcus pyogenes* \[[@CR59], [@CR76], [@CR77]\], among others \[[@CR12], [@CR85]\].

Shigella is a major cause of dysentery worldwide, accounting for up to 165 million cases of shigellosis each year \[[@CR23]\]. Yet, despite there not existing vaccine available as yet, the human and animal challenge--rechallenge trials with virulent Shigella as well as observational studies in Shigella-endemic areas are promising. The incidence of the disease decreased following Shigella's infection which pointsto a biological feasibility of a vaccine \[[@CR54]\]. Phalipon et al. \[[@CR71]\] as well as Mani et al. \[[@CR54]\] proposed that adult zebrafish could be used to study the immune response to Shigella, which is crucial to understanding the crosstalk between Shigella and T-lymphocytes \[[@CR75]\] thus this being relevant in the development of vaccine strategies. Studies have also been conducted with Zebrafish model to promote a vaccine against Salmonella, which produces gastroenteritis that causes massive morbidity and mortality in adults and children in developing countries. Howlader et al. \[[@CR39]\] proved that zebrafish was an excellent model for the study of vaccines using successive immersion triple vaccines with the single serotype *Salmonella. Typhimurium* and *Salmonella entereditis* induced protective efficacy against a high dose (10^8^ CFU/ml) of infection by these pathogens.

Other microorganisms of importance such as fungi which can cause pathologies in humans, such as *Candida albicans* \[[@CR10]\], *Cryptococcus neoformans* \[[@CR8], [@CR84]\] and *Mucor circinelloides* \[[@CR90]\] have also been the subject of study with teleosts. In addition, viruses such as Herpes simplex \[[@CR13], [@CR31]\]; human norovirus \[[@CR88]\]; Vesicular stomatitis \[[@CR33]\]; hepatite C \[[@CR21], [@CR22]\]; Chikungunya \[[@CR1], [@CR9], [@CR14], [@CR68]\]; Sindib \[[@CR69]\] and Influenza A \[[@CR30]\] are some of the human viruses already studied by the zebrafish model in both embryos and larvae.

Conclusions {#Sec9}
===========

The use of the Zebrafish model for the production of vaccines with application for both animals and humans, despite already being a reality, is still underused. This model is an important tool for the development of new safe vaccines against diseases which do not yet have preventive treatment, or for which the existing vaccines are not so effective. Thus, previous screening tests with zebrafish have been proven to be effective in preliminary phases prior to testing with mammalians. Despite the evidence from the literature indicating that science in this field is in its infancy, when compared to other animal models used in research, teleost models have proved to be effective in the elucidation of the infection and immunological responses to the diverse animal and human pathogens. In addition, the reduced financial cost and time frame needed for testing are another attractive regarding the use of zebrafish. Thus, it is expected its use would expand in the coming years.
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